文献速递外周动脉疾病

术中移植物流量对膝下腘动脉及胫动脉自体静脉旁路长期通畅性的预后意义

Prognostic significance of intraoperative graft flow on long-term patency of below knee popliteal and tibial bypasses with autologous vein in patients with chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2025-07-11

该回顾性研究纳入2003年7月至2023年7月间163例因慢性肢体威胁性缺血接受膝下腘动脉或胫动脉自体静脉旁路的患者,共177条旁路,术中测量移植物流量。中位随访47个月,多因素分析显示Rutherford VI级、流量<110 mL/min和复合静脉移植物与通畅性丧失相关;流量>110 mL/min者1年和5年一期通畅率显著更高。

要点

  • 术中移植物流量<110 mL/min是旁路通畅性丧失的独立预测因素。
  • 流量>110 mL/min者1年及5年一期、一期辅助和二期通畅率均显著更高。
  • Rutherford VI级和复合静脉移植物亦与通畅性丧失独立相关。

核心结论

  • 术中移植物流量是膝下腘动脉及胫动脉自体静脉旁路长期通畅性的独立预测因素。

研究设计与样本

  • 回顾性队列研究,纳入2003年7月至2023年7月连续163例患者共177条旁路,术中采用Optima Flow-QC transit-time超声测量移植物流量。

主要发现

  • 中位移植物流量为132 mL/min(膝下腘动脉旁路 vs 胫动脉旁路:150 vs 120 mL/min;P = .054)。
  • 多因素分析显示Rutherford VI级(HR 3.2)、流量<110 mL/min(HR 1.7)和复合静脉移植物(HR 1.7)与通畅性丧失相关。
  • 流量>110 mL/min者1年一期、一期辅助和二期通畅率分别为54%、77%和85%,5年分别为37%、68%和70%。
  • 流量<110 mL/min者1年一期、一期辅助和二期通畅率分别为31%、48%和66%,5年分别为16%、34%和50%(P < .01)。

关键数值与推荐

  • Youden指数用于确定移植物流量截断值为110 mL/min。

临床怎么用

  • 术中移植物流量可辅助调整术后监测方案并考虑抗凝治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intraoperative graft flow (GF) is a quick, composite measure of bypass graft status, encompassing adequacy of conduit, technique as well as inflow/outflow. The aim of this study was to evaluate the prognostic significance of GF on long-term patency of below-knee (BKPB) popliteal and tibial (TB) bypasses performed with autogenous vein conduit in patients with chronic limb-threatening ischemia (CLTI). METHODS: Data from consecutive patients who underwent BKPB or TB for CLTI using autologous vein between July 2003 and July 2023 and had intraoperative GF measurement (Optima Flow-QC transit-time ultrasound) were retrospectively reviewed. Primary endpoints were primary patency (PP), primary assisted patency (PAP), secondary patency (SP), and major limb amputation. Youden index was used to determine cutoff of GF. RESULTS: There were 177 bypasses in 163 patients (68.9% males; median age, 71 years), 68.4% with Rutherford IV ischemia and 31.6% with Rutherford V/VI ischemia. Comorbidities included hypertension (84.2%), diabetes mellitus (49.2%), coronary artery disease (59.3%), and end-stage renal disease (6.8%), and 26% were active smokers. Outflow targets included BKP or TP trunk in 36.2% and tibial in 63.8%. Venous conduits used were single-segment great saphenous vein (57.6%), arm vein (3.4%), and composite vein (39.0%). Median GF was 132 mL/min (BKPB vs TB; 150 vs 120 mL/min; P = .054). Median clinical follow-up was 47 months (interquartile range, 18-98 months). PP, freedom from major amputation, and overall survival at 1 year following BKPB and TB were 57.6%, 100%, and 86.9% and 40.3%, 86.8%, and 88.2%, respectively. On multivariate analysis, Rutherford VI (hazard ratio [HR], 3.2), GF <110 mL/min (HR, 1.7), and composite vein conduit (HR, 1.7) were associated with loss of patency. On Kaplan-Meier analysis, in grafts with GF >110 mL/min, PP, PAP and SP at 1 year (54%, 77%, and 85%) and 5 years (37%, 68%, and 70%) were significantly higher than those with GF <110 mL/min (1 year: 31%, 48%, and 66%; 5 years: 16%, 34%, and 50%; P < .01). CONCLUSIONS: In addition to nonmodifiable factors such as outflow target and composite vein conduit, intraoperative GF flow is an independent predictor of loss of patency of distal bypass grafts with vein conduit in patients with CTLI. This information can be used to modify the surveillance protocol and consider anticoagulation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Vaddavalli VV, Shuja F, DeMartino RR, et al. Prognostic significance of intraoperative graft flow on long-term patency of below knee popliteal and tibial bypasses with autologous vein in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 40653124. doi:10.1016/j.jvs.2025.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。